ADC · 폐암 (NSCLC) | 바이오모아

ADCSFDAFDABiologicFundación Pública Andaluza para…Deruxtecan-Dlnk Quantificat…Phase 3

Datopotamab deruxtecan (Datopotamab deruxtecan)

Breast Cancer; Metastatic Breast Cancer · Lung Cancer

#LungCancer#ADC#Phase3#FDA승인#항체약물접합체+5

효능 ORR 79%임상시험 44상태 RECRUITING

ADCSFDAFDABiologicstaleDaiichi SankyoPhase 2

trastuzumab deruxtecan (Enhertu, T-DXd, DS-8201, Fam-Trastuzumab Deruxtecan-Nxki)

HER2 Mutant Non-small Cell Lung Cancer; HER2-positive Metastatic Breast Cancer · HER2

#HER2#ADC#Phase2#FDA승인#항체약물접합체+4

효능 ORR 71.7%임상시험 23상태 RECRUITING

ADCAFDAFDABiologicstaleAbbViePhase 3

Telisotuzumab Vedotin (Telisotuzumab Vedotin)

Advanced Solid Tumors Cancer · Non Small Cell Lung Cancer

#NonSmallCellLungCancer#ADC#Phase3#FDA승인#항체약물접합체+3

효능 ORR 33.3%임상시험 12상태 RECRUITING

ADCSHotBiologicRocheDM1 via butelase-1 with ABD…Approved

trastuzumab (Herceptin, Trastuzumab Emtansine)

HER2 Mutant Non-small Cell Lung Cancer; HER2-positive Metastatic Breast Cancer · Metastatic Salivary Gland Carcinoma

#MetastaticSalivaryGlandCarcinoma#ADC#Approved#인기#항체약물접합체+5

효능 ORR 80%임상시험 119상태 RECRUITING

ADCBBiologicstaleGileadPhase 2

SG (Sacituzumab Govitecan-hziy, Sacituzumab Govitecan-hziy (SG))

Lung Cancer; Advanced or Metastatic Non-Small-Cell Lung Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase2#인기#항체약물접합체+4

효능 ORR 34.3%임상시험 94상태 RECRUITING

ADCABiologicstaleJanssen Research & Development,…Phase 3

Osimertinib (Osimertinib)

Carcinoma, Non-Small-Cell Lung · FRα

#FR#ADC#Phase3#인기#항체약물접합체+4

효능 ORR 76.7%임상시험 88상태 RECRUITING

ADCBBiologicDaiichi SankyoPhase 2

Fixed dose (Patritumab Deruxtecan, Patritumab Deruxtecan (Fixed dose))

Non-Small Cell Lung Cancer Metastatic; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor · Non-Small Cell Lung Cancer Metastatic

#Non-SmallCellLungCancerMetastati#ADC#Phase2#인기#항체약물접합체+4

효능 ORR 64%임상시험 88상태 RECRUITING

ADCBBiologicDaiichi Sankyoderuxtecan, sacituzumab gov…Phase 2

Up-Titration (Patritumab Deruxtecan, Patritumab Deruxtecan (Up-Titration))

Non-Small Cell Lung Cancer Metastatic; Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor · Non-Small Cell Lung Cancer Metastatic

#Non-SmallCellLungCancerMetastati#ADC#Phase2#인기#항체약물접합체+5

효능 ORR 64%임상시험 88상태 RECRUITING

ADCSBiologicDaiichi Sankyoderuxtecan (Dato-DXd, Datro…Phase 3

DS-8201a (Trastuzumab deruxtecan, Trastuzumab deruxtecan (DS-8201a))

Breast Cancer; Non-small Cell Lung Carcinoma · Breast Cancer

#BreastCancer#ADC#Phase3#인기#항체약물접합체+5

효능 ORR 79.7%임상시험 84상태 RECRUITING

ADCCBiologicNovartis PharmaceuticalsdeliveryPhase 3

Trametinib (Trametinib)

KRAS G12C Mutant Solid Tumors; Carcinoma, Non-Small Cell Lung · FRα

#FR#ADC#Phase3#인기#항체약물접합체+5

효능 ORR 100%임상시험 79상태 DISCONTINUED

ADCCBiologicMerck Sharp & Dohme LLCPhase 3

Rescue Medication (Rescue Medication)

Non Small Cell Lung Cancer · Triple Negative Breast Neoplasms

#TripleNegativeBreastNeoplasms#ADC#Phase3#인기#항체약물접합체+3

임상시험 69상태 RECRUITING

ADCBiologicHoffmann-La Rochevedotin (ARON-2EV study)Approved

Platinum Based Chemotherapy (Platinum Based Chemotherapy)

Non-Squamous Non-Small Cell Lung Cancer · Ovarian Cancer

#OvarianCancer#ADC#Approved#인기#항체약물접합체+4

효능 ORR 66%임상시험 68상태 RECRUITING

ADCBiologicAstraZenecaVedotin in a Hemodialysis P…Phase 3

Gemcitabine/Carboplatin (Gemcitabine/Carboplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Muscle Invasive Bladder Urothelial Carci

#MuscleInvasiveBladderUrothelialC#ADC#Phase3#인기#항체약물접합체+5

효능 ORR 69.6%임상시험 67상태 ACTIVE

ADCBiologicAstraZenecaPhase 3

Pemetrexed/Carboplatin (Pemetrexed/Carboplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+3

효능 ORR 87.5%임상시험 67상태 RECRUITING

ADCBiologicAstraZenecaPhase 3

Carboplatin/Paclitaxel (Carboplatin/Paclitaxel)

Advanced Ovarian Cancer · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+4

효능 ORR 75%임상시험 66상태 RECRUITING

ADCBiologicMerck Sharp & Dohme LLCPhase 3

Rescue medications (Rescue medications)

Lung Neoplasm Malignant · Endometrial Cancer

#EndometrialCancer#ADC#Phase3#인기#항체약물접합체+4

임상시험 66상태 RECRUITING

ADCBiologicNovartis PharmaceuticalsPhase 2

Ribociclib (Ribociclib)

KRAS G12C Mutant Solid Tumors; Carcinoma, Non-Small Cell Lung · Breast Cancer

#BreastCancer#ADC#Phase2#인기#항체약물접합체+5

효능 ORR 66.7%임상시험 66상태 RECRUITING

ADCBiologicMerck Sharp & Dohme LLCPhase 2

Corticosteroid (Corticosteroid)

Carcinoma, Non-Small-Cell Lung · Carcinoma, Non-Small-Cell Lung

#CarcinomaNon-Small-CellLung#ADC#Phase2#인기#항체약물접합체+4

효능 ORR 5.6%임상시험 65상태 RECRUITING

ADCBiologicCaicun ZhouSN-38, indicated by higher …Phase 2

Gefitinib (Gefitinib)

Non-small-cell Lung Cancer · Non-Small Cell Lung Cancer

#Non-SmallCellLungCancer#ADC#Phase2#인기#항체약물접합체+4

효능 ORR 74.9%임상시험 64상태 ACTIVE

ADCBiologicAstraZenecaPhase 3

Pemetrexed/Cisplatin (Pemetrexed/Cisplatin)

Non-Small-Cell Lung Carcinoma NSCLC · Non-small Cell Lung Cancer

#Non-smallCellLungCancer#ADC#Phase3#인기#항체약물접합체+4

효능 ORR 87.5%임상시험 64상태 RECRUITING

1 / 6 페이지

← 이전다음 →